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ABSTRACT: Although the biomimetic dimetal complex
[LGa2(OH)2(H2O)2]
3+ [L = 2,6-bis((N,N′-bis(2-picolyl)-
amino)methyl)-4-tertbutylphenolate] provides eﬃcient pro-
tection against phosphate loss in phosphopeptides upon
collision-induced dissociation tandem mass spectrometry
(CID MS/MS), the underlying mechanism remains unknown.
Here, we explored the mechanism in detail and investigated
the selective binding to phosphate groups in solution. Dimetal
complexes containing combinations of Ga3+, In3+, Fe3+, Co3+,
Zn2+, Cu2+, and V2+ were reacted with HPO4
2−, phosphoserine,
and a phosphopeptide (FQpSEEQQQTEDELQDK, abbre-
viated “βcas”) and studied with isothermal titration calorimetry
(ITC), CID MS/MS, and density functional theory (DFT). Ka
for HPO4
2− binding scaled with the metal charge and was 35-fold larger for [LGa2(OH)2(H2O)2]
3+ (3.08 ± 0.31 × 106 M−1)
than for [LZn2(HCOO)2]
+. CID MS/MS of [LGa2(βcas)]
n+ revealed protection against phosphate detachment (<3% of the total
ion intensity). Phosphate detachment from βcas was 22−40% and increased to 42−71% when bound to dimetal complexes of
lower charge than {LGa2}
5+. CID data suggests that facile metal−phosphate dissociation is associated with proton transfer from
the intermediate oxazoline ring formed in the phosphopeptide to the metal−phosphate complex. The observed phosphate
stabilization was attributed to a signiﬁcant reduction in the gas-phase basicity (GB) of the phosphate group when bound to
{LGa2}
5+/{LIn2}
5+ complex cores. Absence of proton transfer results in formation of an ion−zwitterion intermediate with a
greater dissociation threshold. This hypothesis is supported by DFT calculations for [LGa2(PO4)]
2+, [LGaZn(PO4)]
+,
[LZn2(PO4)], and 2,4-dimethyl-3-oxazoline showing that [LGa2(PO4)]
2+ is the only compound with a substantial lower GB (321
kJ/mol less) than 2,4-dimethyl-3-oxazoline.
Phosphorylation of speciﬁc amino acid residues in proteinsis among the most common protein modiﬁcation in higher
organisms.1 For many years, protein phosphorylation has
received considerable attention in scientiﬁc and clinical research
since it is essential in many biological processes, including
signal transduction, cell division, gene expression, cytoskeletal
regulation, and metabolic maintenance.1,2 Mass spectrometry is
the current dominating analytical method for characterization
of protein phosphorylation. Typically, sequencing and local-
ization of protein phosphorylations is accomplished by tandem
mass spectrometry (MS/MS) of their corresponding phospho-
peptides. The MS/MS step is a particular challenge due to the
signiﬁcant gas-phase lability of phosphate ester bonds in
peptide ions.3 The result is a predominant loss of the phosphate
group (e.g., H3PO4) during MS/MS when utilizing collision-
induced dissociation (CID), which in turn hampers cleavage of
sequence speciﬁc backbone bonds. This complicates both
downstream peptide identiﬁcation and reliable determination of
the phosphorylation site.4−6 Ways of addressing this issue
include fragmentation strategies employing MS3 scans from
neutral loss-containing ions and multistage activation of both
precursor ions and ions of phosphate neutral losses.7,8 Recently
enzymatic removal of C-terminal arginine or lysine from
phosphopeptides has been shown to decrease the loss of
phosphoric acid during CID.9 Also methods of advanced data
interpretation have been applied to obtain site-localization of
the phosphate group in CID spectra via scoring algo-
rithms.10−17 Fragmentation techniques relying on electron-
driven ion excitation such as electron-capture dissociation
(ECD)18 and electron-transfer dissociation (ETD)19 do not
induce signiﬁcant detachment of labile modiﬁcations due to a
high rate of bond cleavage and low amount of excess electronic
energy.20−22 Obtaining similar protection against phosphate
loss in CID would be a signiﬁcant gain to phosphoproteomics.
In a recent publication we proposed a methodology of
phosphate ester protection provided by speciﬁc reaction of a
biomimetic digallium complex to phosphate ester groups in
phosphopeptides.23 The reaction described in the “dimetal
phosphate ester stabilization” (DIMPES) methodology consists
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of dissolution of a dimetallic complex [LGa2(OH)2(H2O)2]-
(ClO4)3 and substitution of the water-derived auxiliary ligands
by the phosphate ester groups found in phosphopeptides.
When attempting to bind the phosphate groups selectively the
most signiﬁcant competing anionic species will invariably be
carboxylate. This functional group resides on two common
amino acids, glutamic and aspartic acid, as well as the C-
terminus. A peptide likely contains several of these amino acids,
and the situation will often be a large excess of carboxylate
relative to phosphate groups. It is therefore interesting to
identify a reagent with the best ability to discriminate against
unspeciﬁc binding. Challenges with low speciﬁcity are often
observed during enrichment procedures such as immobilized
metal aﬃnity chromatography (IMAC).24−26 An additional
requirement is to provide eﬃcient protection of phosphate
ester groups in tandem MS/MS such as CID. Here we report a
systematic study assessing the analytical eﬀect on selectivity and
phosphate protection observed when the metal ions, Ma and
Mb, in a biomimetic dimetallic [LMaMb(X)]
n+ precursor
complex are varied (X = labile auxiliary ligands). Understanding
the mechanism behind phosphate ester protection by dimetal
complexes will add important knowledge to the ﬁeld of
analytical chemistry, which may provide opportunities for
further developments and applications of metal chemistry in
mass spectrometry-based phosphoproteome analysis.
■ EXPERIMENTAL SECTION
Materials. Chemicals were purchased from Sigma-Aldrich
and used as received. βcas phosphopeptide (FQpSEEQQQT-
EDELQDK) was purchased from Anaspec, Inc. (Fremont, CA,
USA). Alkaline phosphatase was purchased from Roche (Basel,
Schweiz). Some phosphopeptides were desalted prior to MS
using in-house-packed Poros Oligo R3 microcolumns. LH (2,6-
bis((N,N′-bis(2-picolyl)amino)methyl)-4-tertbutylphenol),27
[LGa2(OH)2(H2O)2](ClO4)3,
28 [LIn2(CH3CO2)2](ClO4)3,
28
[LZn2(HCO2)2](ClO4),
28 [L(VO)2(H2O)2](ClO4)3·H2O,
29
[LFeZn(CH3CO2)2](ClO4)2,
27 [LCo2(μ-H3O2)2](ClO4)3·
2H2O,
30 and [LCu2(OCH3)](ClO4)2·H2O
31 were prepared as
previously described. The procedures for the synthesis of the
remaining complexes, dephosporylation, and methylation of
carboxylic acids in βcas are presented in the Supporting
Information. IR spectra were measured as KBr disks on a
Hitachi 270-30 IR spectrometer. NMR spectra were recorded
using a Bruker Avance III spectrometer (400 MHz). Micro-
analyses were performed at the Department of Chemistry,
University of Copenhagen. CAUTION! Although we encountered
no problems during preparations, perchlorate salts of metal
complexes are potentially explosive and should be handled with
caution in small quantities.
Mass Spectrometry. Nanoneedles for oﬀ-line electrospray
were purchased from Thermo Fisher Scientiﬁc or Proxeon.
Mass spectra were obtained on an Orbitrap XL mass
spectrometer (Thermo Fisher). Solutions were diluted to ∼5
μM (5:1 MeCN/H2O) prior to MS analysis. All mass spectra
were recorded in the positive ion mode with 10 000−30 000
resolving power using the Orbitrap analyzer. Typical settings
were spray voltage = 1−1.10 kV, capillary temperature = 200
°C, capillary voltage = 49 V, tube lens voltage = 100 V, with
max injection time of 500 ms. Each spectrum was averaged over
30−60 acquisitions comprising 2−3 scans and recorded after
steady electrospray conditions were obtained.
Phosphate Ester Binding Aﬃnity. Experiments were
conducted using aqueous solutions containing 2.5 mM
phosphoserine (pSer) mixed with 2.5, 25, or 125 mM serine
(Ser). Dimetallic complexes were dissolved in 5:1 MeCN/H2O
to a ﬁnal concentration of 2.5 mM and added to the amino acid
solutions (ratio of metal complex to pSer was 1:1, ﬁnal pH 4−
5). The mixtures were allowed to react for 3 h before being
diluted to 5 μM and studied with electrospray ionization mass
spectrometry (ESI-MS).
Isothermal Titration Calorimetry (ITC). Measurements
were carried out on a VP-ITC microcalorimeter (GE
Healthcare Life Sciences). A 2.47 mM aqueous solution of
Na2HPO4 in 10 mM HEPES buﬀer pH = 7.1 was titrated into
1.4095 mL of a 0.1−0.2 mM aqueous solution of metal
complex in 10 mM HEPES buﬀer (V = 7 μL). All
measurements were carried out at 30 °C and obtained in
triplicate with a reference power of 25 μcal/s. The
thermodynamic constants were found by ﬁtting to the one-
site binding model included in the software (Origin) supplied
with the instrument.
Computational Methods. The low-energy structure of
2,4-dimethyl-3-oxazoline and its N-protonated species were
obtained through conformational searching using MM2 force
ﬁeld. Starting geometries for [LGa2(PO4)]
2+, [LGaZn(PO4)]
+,
and [LZn2(PO4)] were derived from the X-ray crystal structure
of [LGa2(OH)2(OH2)2](ClO4)3(2(ClO4)3)
23 after substituting
auxiliary ligands (OH)2(OH2)2 with (PO4
3−) and metal ions as
appropriate. For gas-phase basicity (GB) estimations a proton
was added to each of the minimized conjugated bases and
MM2 force ﬁeld were applied to detect other possible low-
energy structures. Calculations were performed using the
Gaussian 09 suite of programs.32 All geometries were optimized
using the DFT (density functional theory) B3LYP level of
theory and 6-31G basis set. For higher accuracy, single-point
energies of optimized structures were calculated with the same
level of theory using 6-31+G(d,p) basis set after adding both
polarization and diﬀuse functions for heavy atoms and
hydrogens. Identiﬁcation of local minima was obtained by
energy minimization yielding positive harmonic vibrational
frequencies. Zero-point energies and Gibbs free energy
corrections at 298 K were computed using vibrational
frequencies and adjusted by an appropriate correction factor
of 0.9613.
■ RESULTS AND DISCUSSION
The inspiration for designing the dimetal complexes in this
study stems from the biologically known metalloenzymes of
purple acid phosphatase,33 urease,34 alkaline phosphatase,35 and
an organophosphate-degrading enzyme.36 36 In these impor-
tant enzymes phosphate and alkylphosphate groups act as
bridging ligands (μ−η1,η1-bridges) and can be both substrates
and inhibitors. The existence of these moieties suggests that
dimetallic sites play important roles in the traﬃcking and
metabolism of inorganic phosphates and organophosphates.
Biomimetic dizinc complexes of acyclic phenolato and alkylato-
hinged dinucleating ligands have been employed as receptors
for the recognition and binding of phosphate, pyrophosphate,
and phosphate monoester species.37−40 The use of metal ions
other than zinc in the complex will aﬀect the aﬃnity for and
chemical properties of phosphate groups upon binding to the
dimetal site as evidenced by a closely related divanadyl complex
[L(VO)2(HCOO)](ClO4)2, which shows surprisingly diﬀerent
aﬃnities for the very similar tetraoxoanions of phosphate and
arsenate.41 This is a remarkable observation given the
insigniﬁcant size and charge diﬀerences between these anions.
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Ten dimetallic complexes ([LGa2(OH)2(H2O)2](ClO4)3,
[LIn2(CH3CO2)2](ClO4)3, [LCo2(OH)2(H2O)2](ClO4)3,
[LGaZn(CH3CO2)2](ClO4)2, [LGaCu(CH3CO2)2](ClO4)2,
[LFeZn(CH3CO2)2](ClO4)2, [LInCu(CH3CO2)2](ClO4)2,
[LZn2(HCOO)2](ClO4), [LCu2(CH3O)](ClO4)2, and [L-
(VO)2(H2O)2](ClO4)3) were synthesized as described in the
Supporting Information. The structure of these dimetallic
complexes without auxiliary ligands (e.g., water-derived,
phosphato, carbolxylato) is shown in Figure 1.
The dimetal complexes were chosen to cover a range of
charges, sizes, and electronic structures while maintaining stable
structures which could be characterized.
Phosphate Ester Binding Aﬃnity. To evaluate the
selectivity of the diﬀerent metal complexes toward phosphory-
lated amino acids, aqueous solutions containing 1:1, 1:10, and
1:50 mol ratios of phosphoserine (pSer) with serine (Ser) were
prepared. These solutions were left to react with each dimetallic
complex for 3 h. From the mass spectra obtained, the
percentage of signal intensity corresponding to ions of dimetal
complex bound to pSer was determined. The spectra of
[LZn2(HCOO)2]
+ and [LGa2(OH)2(H2O)2]
3+ in the presence
of pSer/Ser 1:50 are shown in Figure 2 as an example.
For a few complexes, it was found that one pSer and one Ser
were bound simultaneously. In these cases the ion containing
mixed pSer/Ser did not contribute to selectivity and was not
counted toward total bound pSer. The results of the
competition experiments are depicted in Figure 3.
The selectivity of the diﬀerent complexes for pSer/Ser is
likely determined by the lability of the departing auxiliary
ligands and the stability of the complexes formed with pSer/
Ser. The amino acid pSer has both a carboxylate and a
phosphate group, either of which could potentially coordinate
in a bridging mode to the cationic dimetallic complexes. Gas-
phase ions corresponding to pSer bound to metal complexes
were isolated and fragmented with CID to conﬁrm the binding
mode. Complexes reacting with pSer were all found to bind
through the phosphate group because only ions of the type
[LMaMb(HxPO4)]
n+ (n and x depend on the identity of MaMb)
were observed as fragment ions. The metal complexes that
reacted with more than one pSer (Figure 4) generally lost an
intact pSer (or Ser) during CID. With the exception of
[LGa2(OH)2(H2O)2]
3+ most of the complexes progressively
bound less pSer as the ratio of competing carboxylate anions
was increased (Figure 3). With a few exceptions, the complexes
were found to be selective toward pSer over Ser at 1:1 ratios as
expected by electrostatic considerations and the geometry of
the dimetallic binding site favoring tetraoxoanions. The lower-
charged meta l complexes [LCu2(OCH3)]
2+ and
[LZn2(HCOO)2]
+ did not show any selectivity for either
pSer or Ser relative to formate (present as auxiliary ligand) or
solvent-derived hydroxide/methoxide. Besides selective binding
it is important to consider the binding eﬃciency of the
dimetallic complexes (i.e., how much pSer remains unbound).
Since equimolar amounts of dimetallic complex and pSer was
added it can be inferred that free pSer was present if ion signals
from unreacted dimetal complexes were observed. From Figure
2 it is clear that in the presence of [LGa2(OH)2(H2O)2]
3+ no
pSer remains unbound. This was a lso true for
[LIn2(CH3CO2)2]
3+ while the remaining complexes did not
show 100% binding eﬃciency (at equimolar concentrations).
Figure 1. Generic structure of the [LMaMb]
n+ cation. For clarity
auxiliary ligands and counteranions are not shown.
Figure 2. ESI-MS of MeCN/H2O 5:1 solution containing 50-fold
molar excess of Ser relative to pSer with either (a) [LZn2(HCOO)2]-
(ClO4) or (b) [LGa2(HO)2(H2O)2](ClO4)3. Peaks marked with #
contain Ser. Peaks marked with ∗ contain pSer.
Figure 3. Relative abundance of ions containing pSer bound to a
dimetal complex at diﬀerent concentrations of competing Ser. Green
bars: equimolar Ser. Blue bars: 10-fold excess of Ser. Red bars: 50-fold
excess of Ser (relative to pSer). Each bar represents the average value
obtained from at least 60 spectra.
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Binding Features of Metal Complexes by Charge.
Homometallic M3+, M3+ Complexes. The complexes
[ LM 2 (OH) 2 (H 2O ) 2 ]
3 + M = Ga 3 + , C o 3 + a n d
[LIn2(CH3CO2)2]
3+, each with two 3+ metal ions, were used
as precursors in the tagging experiments. Despite eﬀort we were
unable to isolate exactly analogous precursors, i.e., either
[LM2(OH)2(H2O)2]
3+ or [LM2(CH3CO2)2]
3+, and already this
hinted at possible selectivity diﬀerences of the dimetallic
bridging sites toward potentially bridging oxoanions, despite
the same high charge of the dimetallic core {LM2}
5+. There is a
diﬀerence in the ionic radii of these metal ions (80 vs 62 pm for
six-coordinated In3+ and Ga3+, respectively42), and this together
with the larger bite angle of a μ−η1,η1-carboxylato versus a
μ−η1,η1-phosphato group might be enough to induce the
observed selectivities. Co3+ is known to yield kinetically robust
c o m p l e x e s . 4 3 C o n s i s t e n t l y n o r e a c t i o n o f
[LCo2(OH)2(H2O)2](ClO4)3 with pSer or Ser was observed,
and the complex was not included in further experiments. The
favored stoichiometry of coordinated pSer was not the same for
{LGa2}
5+ and {LIn2}
5+ (Figure 4). {LGa2}
5+ was found to form
ions of the type [LGa2(pSer − 3H)]2+ in 95% of cases. In
contrast, {LIn2}
5+ formed [LIn2(pSer − 3H)]2+ only 33% of the
time. This diﬀerence reﬂects the larger ionic radii of In3+
compared to Ga3+ leading to a higher charge density for Ga3+.
At 50-fold Ser concentration (relative to pSer), ∼7% of the
intensity in spectra of {LIn2}
5+ consisted of ions with mixed
auxiliary ligands of the type [LIn2(pSer − 2H)(Ser − H)]2+. In
none of the experiments was [LGa2(OH)2(H2O)2]
3+ observed
to bind Ser.
Heterometallic M3+, M2+ Complexes. The acetate-bridged
complexes [LFeZn(CH3CO2)2]
2+, [LGaCu(CH3CO2)2]
2+, and
[LGaZn(CH3CO2)2]
2+ demonstrated large diﬀerences in pSer
selectivity. At a 1:1 ratio of pSer/Ser the selectivity decreased in
the order of [LFeZn(CH3CO2)2]
2+ ≈ [LGaCu(CH3CO2)2]2+ >
[LGaZn(CH3CO2)2]
2+ with [LFeZn(CH3CO2)2]
2+ binding
∼60% more pSer than [LGaZn(CH3CO2)2]2+. If the pSer/
Ser ratio was changed to 1:50, [LFeZn(CH3CO2)2]
2+ was still
reasonably selective toward pSer, binding close to 70%.
[LGaCu(CH3CO2)2]
2+ and [LGaZn(CH3CO2)2]
2+ bound
67% and 25% pSer, respectively. The stoichiometries of the
ions formed by the reaction of pSer/Ser with [LFeZn-
(CH3CO2)2]
2+ and [LGaCu(CH3CO2)2]
2+ are listed in Figure
4.
Homometallic M2+, M2+ Complexes. [LZn2(HCOO)2]
+,
[LCu2(OCH3)]
2+, and [L(VO)2(H2O)2]
3+ demonstrated large
diﬀerences in pSer aﬃnity. All product ions containing either
pSer or Ser were of the type [LM2(pSer − H)]2+ or [LM2(Ser
− H)]2+. Both [LZn2(HCOO)2]+ and [LCu2(OCH3)]2+
appeared to form very weak complexes with pSer/Ser. This
resulted in an overall low selectivity consistent with the
Figure 4. Proposed structures of the major ions observed in mass spectrometry of dimetallic compounds (1 equiv) and mixtures of 1:50 pSer/Ser.
Minor ions (>3% relative signal intensity) are listed below in nonbold type. Ligands OH−, O2−, HCOO−, and OAc− are either present in the crystals
of the dimetal complexes or derived from solvent. RO− = L−, Ra = C3H6NO2 (pSer), and Rb = C2H6NO (Ser).
Table 1. Ka for Reaction between Dimetal Complexes and Na2HPO4 by ITC at 30 °C in 10 mM HEPES buﬀer, pH 7.1
complex Ka [10
6 M−1] technique ref
[LGa2(OH)2(H2O)2](ClO4)3 3.08 ± 0.31 ITC 28
[LIn2(CH3CO2)2](ClO4)3 1.22 ± 0.27 ITC 28
[LFeZn(CH3CO2)2](ClO4)2 0.14 ± 0.04 ITC this work
[L(VO)2(H2O)2](ClO4)2
a ITC this work
[LGaCu(CH3CO2)2](ClO4)2 0.14 ± 0.02 ITC this work
[LGaZn(CH3CO2)2](ClO4)2
a ITC this work
[LZn2(HCOO)2](ClO4) 0.09 ± 0.01 ITC 28
[LCu2(OCH3)](ClO4)
a ITC this work
[(bpmp)Zn2]
3+, 10 mM HEPESb 0.11 ± 0.01 ITC 37
[(bpanth)Zn2](NO3)4, 10 mM HEPES
c 0.42 ﬂuorescence 44
aSolubility of the compound was too low to yield measurable binding heats. bHbpmp = 2,6-bis((N,N′-bis(2-picolyl)amino)methyl)-4-methylphenol;
no counteranion reported. cbpanth = 1,8-bis((N,N′-bis(2-picolyl)amino)methyl)-anthracene.
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observation of ions with diﬀerent auxiliary ligands in the mass
spectra (Figure 2). The vanadyl complex [L(VO)2(H2O)2]
3+
selectively bound pSer at 1:1 and 1:10 ratios of pSer/Ser (95%
of ions contain pSer). At 1:50 pSer/Ser the selectivity was,
however, lost as 33% of the formed ions contained Ser.
Association Constants, Ka. Association constants (Ka) for
the binding of the phosphate moiety to diﬀerent dimetal
complexes were determined using ITC. Since the dilution heat
produced when titrating pSer into 10 mM HEPES buﬀer (pH
7.1) was greater than the heat of binding to the metal
complexes, Na2HPO4 was chosen as substrate instead.
Incidentally this made it possible to compare the Ka of our
dimetal complexes to two previously published related dizinc
complexes based on the ligands (2,6-bis((N,N′-bis(2-picolyl)-
amino)methyl)-4-methylphenolate) (bpmp−)37 and (1,8-bis-
((N,N′-bis(2-picolyl)amino)methyl)-anthracene) (here de-
noted bpanth)44 The Ka for these complexes, as well as those
obtained in this study, are given in Table 1.
As expected, the Ka were found to be largest for the
complexes with two 3+ metal ions (digallium and diindium,
∼106 M−1) and generally decreased with decreasing charge
states of the metals. Of the complexes with two M2+ metal ions,
only [LZn2(HCOO)2]
+ produced measurable heat of binding
when titrated with Na2HPO4. Ka for [LZn2(HCOO)2]
+ was
found to be 8.60 × 104 M−1 or approximately 35 times lower
than that of [LGa2(OH)2(H2O)2]
3+. Ka for two previously
published bis(2-picolyl)amine-based dizinc complexes, which
have been tested as receptors for phosphate under similar
conditions, are listed at the end of Table 1. [(bpmp)Zn2]
3+
complexes were found to have a slightly higher Ka than we
report here for [LZn2(HCOO)2]
+. Such a relatively small
diﬀerence is likely caused by small variations in pH or
concentrations. The second dizinc complex [L1Zn2]
4+ was
measured by ﬂuorescence spectroscopy to have a Ka of 4.2 ×
105 M−1. The heterometallic M3+, M2+ complexes [LFeZn-
(CH3CO2)2]
2+ and [LGaCu(CH3CO2)2]
2+ showed very similar
Ka at ∼105 M−1 (Table 1), while [LGaZn(CH3CO2)2]2+ yielded
almost no signal due to low solubility in water. These results
showed that the solution Ka correlates well with the selectivity
experiments (Figure 3) in the sense that the complexes with the
largest Ka were found also by MS to be the most selective with
respect to phosphate binding. Binding isotherms are presented
in the Supporting Information, Figures S2 and S3.
Phosphate Group Stabilization. The dimetallic precursor
complexes were mixed with the βcas phosphopeptide (FQ-
pSEEQQQTEDELQDK, abbreviated βcas) in 1.2:1 ratio in
H2O/MeCN 1:1 and left to stand for 3 h, 25 °C. The most
abundant mass spectrometric product signals were assigned to
[LMaMb(βcas)]
n+-type ions (n = 3 or 4, the protonation state of
the peptide varies). To study the eﬀect of phosphate ester
protection provided by DIMPES, [LMaMb(βcas)]
n+ ions were
fragmented with CID. The amount of phosphate lost from each
[LMaMb(βcas)]
n+ was determined as the ratio of the summed
abundance of all phosphate loss signals (neutral loss from the
precursor ions, from fragment ions, and the metal complex
bound phosphate), divided by the summed ion abundance of
the most intense fragment ions (counted up to 200). In the
case of βcas phosphopeptide, the predominant loss was neutral
H3PO4, whereas most of the metal complex bound peptides
predominantly lost phosphate as [LMaMb(HnPO4)]
2+ or
[LMaMb(HnPO4)]
+ (n = 0, 1, or 2) (Table 2).
For βcas the loss of H3PO4 from precursor and fragment ions
in CID corresponded to approximately 40% and 22% of the ion
intensity for 2+ and 3+ precursor ions, respectively.
Interestingly, CID of βcas bound to {LGa2}
5+ resulted in
phosphate losses of only 1% and 3% from 3+ and 4+ precursor
ions, respectively. Phosphate was lost from [LGa2(βcas −
2H)]3+ and [LGa2(βcas − H)]4+ exclusively as [LGa2(PO4)]2+,
m/z 402.0631, conﬁrming the digallium metal complex to be
coordinated to the phosphate group (Supporting Information,
Figure S1). Notably, metal complexes containing any
combination of metal ions other than two Ga3+ resulted in an
increased phosphate loss (from 42% for [LGaZn(βcas)]4+ up to
71% for [LGaZn(βcas − H)]3+). The fact that the diindium
complex resulted in increased phosphate loss was surprising
since it has the same net charge as the digallium complex.
Table 2. Percentage Loss of H3PO4/[LMaMb(HnPO4)]
+/2+ in CID MS/MS
precursor dimetal complex/peptide selected ion phosphate loss [%]
βcasa [βcas + 2H]2+ 40
βcasa [βcas + 3H]3+ 22
[LGa2(OH)2(OH2)2](ClO4)3 [LGa2(βcas − 2H)]3+ 1.0
[LGa2(OH)2(OH2)2](ClO4)3 [LGa2(βcas − H)]4+ 2.9
[LGaZn(CH3CO2)2](ClO4)2 [LGaZn(βcas − H)]3+ 71
[LGaZn(CH3CO2)2](ClO4)2 [LGaZn(βcas)]
4+ 42
[LFeZn(CH3CO2)2](ClO4)2 [LFeZn(βcas − H)]3+ 66
[LFeZn(CH3CO2)2](ClO4)2 [LFeZn(βcas)]
4+ 65
[LZn2(HCOO)2](ClO4) [LZn2(βcas − H)]2+ 51
[LZn2(HCOO)2](ClO4) [LZn2(βcas)]
3+ 51
[LCu2(OCH3)](ClO4)2 [LCu2(βcas − H)]2+ 65
[LCu2(OCH3)](ClO4)2 [LCu2(βcas)]
3+ 60
[L(VO)2(H2O)2](ClO4)3 [L(VO)2(βcas − H)]2+ 61
[L(VO)2(H2O)2](ClO4)3 [L(VO)2(βcas)]
3+ 69
[LGaCu(CH3CO2)2](ClO4)2 [LGaCu(βcas − H)]3+ 66
[LGaCu(CH3CO2)2](ClO4)2 [LGaCu(βcas)]
4+ 54
[LIn2(CH3CO2)2](ClO4)3 [LIn2(βcas − 2H)]3+ 43
[LIn2(CH3CO2)2](ClO4)3 [LIn2(βcas − H)]4+ 53
[LInCu(CH3CO2)2](ClO4)3 [LInCu(βcas − H)]3+ 69
[LInCu(CH3CO2)2](ClO4)3 [LInCu(βcas)]
4+ 57
aβcas = FQpSEEQQQTEDELQDK.
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Fragmentation Channels for Phosphate Losses in
DIMPES. As illustrated in Figure 5, the distribution of various
forms of phosphate losses obtained by CID activation of
[LMaMb(βcas)]
3+ can be divided into two fragmentation
channels (A and B). Channel A resulted in loss of mass
equivalent to both phosphate and metal complex. It is assumed
that the metal complex was bound to the phosphate group and
upon CID activation the phosphate ester bond was broken.
This interpretation is supported by two observations: (1) the
appearance of ions of the type [LMaMb(HnPO4)]
2+, n = 0, 1, or
2, depending on the charge of the metal complex and (2) the
absence of ions in the CID spectra belonging to metal
complexes without phosphate. Channel A accounted for more
than 90% of the loss of phosphate from most of the
[LMaMb(βcas)]
3+ irrespective of the species of Ma and Mb.
In fragmentation channel B, a 97.98 Da loss corresponding to
H3PO4 was observed. Both accurate mass and isotopic
distribution of the remaining ions suggests that the metal
complex was retained on the peptide while H3PO4 was lost. For
[LFeZn(βcas − H)]3+, [LGaZn(βcas − H)]3+, [LGaCu(βcas −
H)]3+, [L(VO)2(βcas)]
3+, [LCu2(βcas)]
3+, [LZn2(βcas)]
3+, and
[LGa2(βcas − 2H)]3+ this pathway accounted for less than 10%
of the total phosphate loss based on intensity and may be
explained by unspeciﬁc binding. Phosphopeptide ions with
{LIn2}
5+ were dominated by fragmentation through channel B
and produced 100% H3PO4 loss. A possible explanation is
binding of this metal complex to other competing functional
groups in the phosphopeptide such as carboxylate groups. To
investigate this, βcas was dephosphorylated prior to the
reaction with the diindium complex. Under the same
conditions as the reactions with native βcas, approximately
31% of the mass spectral abundance could be assigned to
[LIn2(dephosβcas)]
n+. It was also observed that at higher
amounts of complex (∼5 equiv) almost all the dephosphory-
lated peptide had reacted. However, the peptide was never
found to bind more than one diindium complex even though
the peptide has seven carboxylic acids. In another experiment,
carboxylic acids of the βcas phosphopeptide were methylated
prior to addition of [LIn2(CH3CO2)2]
3+ (Figure 6).
The mass spectrum of the methylated βcas phosphopeptide
with [LIn2(CH3CO2)2]
3+ conﬁrmed reaction between the
metal complex and the phosphopeptide by the appearance of
an ion which could be assigned to [LIn2(methβcas − H)]4+
(m/z 740.2651, <1 ppm). This conjugate was isolated and
fragmented by CID (Figure 6b), which aside from backbone
cleavages gave rise to a signiﬁcantly reduced amount of
phosphate loss as [LIn2(PO4)]
2+ (m/z 448.0383) and no loss of
phosphoric acid. These results conﬁrmed that if the carboxylate
groups in the phosphopeptide were blocked {LIn2}
3+ binds to
Figure 5. Branching ratios for loss of phosphate containing species from diﬀerent [LMaMb(βcas)]
3+ ions in CID MS/MS. In channel A the dimetal
complex remains coordinated to the phosphate on detachment from the peptide. In channel B a rearrangement is proposed to take place and the
metal complex remains coordinated to the peptide while H3PO4 is lost. The ratios of the phosphate loss between channels A and B are given for
diﬀerent combinations of Ma, Mb. For complexes that form phosphate loss ions with several protonation states the dominant ions have been
highlighted in green. The percent intensity of the diﬀerent protonation states is given in parentheses.〰 = βcas.
Figure 6. CID MS/MS spectra of (a) [LIn2(βcas − 2H)]3+ m/z
953.31 (unlabeled peaks belong to unidentiﬁed fragment ions) and (b)
[LIn2(methβcas − H)]4+ m/z 740.27. Red peaks denote phosphate
loss.
Analytical Chemistry Article
DOI: 10.1021/acs.analchem.5b00257
Anal. Chem. 2015, 87, 7060−7068
7065
the phosphate group and does not migrate upon CID
activation.
Table 3 lists the amount of phosphate loss from methylated
βcas and [LGa2(methβcas)]
n+ or [LIn2(methβcas)]
n+. All
together, these results demonstrate that {LIn2}
3+ either binds
(1) the carboxylate groups unless these are blocked or (2) that
the energy added to the complex−peptide conjugate during
CID MS/MS allows the metal complex to migrate from
phosphate to one or more carboxylate groups releasing H3PO4
in the process. The dephosphorylation/methylation experi-
ments did not prove either of the two possibilities. However,
the competition experiments with pSer and Ser provides
support for the hypothesis that {LIn2}
3+ preferentially
coordinates to the phosphate ester group (Figure 3). In the
case where no carboxylate group is available the complex
remains coordinated to the phosphate ester, and it has the same
protective power as {LGa2}
3+. These results highlight that
phosphate ester protection is both a function of metal charge
state and size.
Proposed Mechanism of Phosphate Group Protec-
tion. The results presented show that protection against
phosphate loss in DIMPES is largely dependent on the charge
state and ionic radii of the metal ions. Only metal complex
cores with a net charge of 5+ ({LGa2}
5+ or {LIn2}
5+) reduce
detachment of the phosphate group in CID (although in the
case of {LIn2}
5+ carboxylate groups must be blocked ﬁrst) while
all other metal complexes show enhanced losses of phosphate
compared to the βcas ions. A notable diﬀerence between
phosphate losses from diﬀerent [LMaMb(βcas)]
n+ was the
extent of protonation of the phosphate group (Figure 5). The
limited losses observed from [LGa2(βcas − 2H)]3+ and
[LGa2(βcas − H)]4+ exclusively led to ions of the type
[LGa2(PO4)]
2+, which contain a fully deprotonated phosphate
group, and the same type of ions were produced when
[LIn2(methβcas − 2H)]3+ and [LIn2(methβcas − H)]4+ were
fragmented with CID. When Ma
2+, Mb
2+ or Ma
3+, Mb
2+ metal
ions were included in the complex the lost phosphate group
was protonated either once or twice to form ions of the type
[LMaMb(HPO4)]
2+ (Ma = Fe
3+, Mb = Zn
2+ and Ma = Ga
3+, Mb
= Zn2+ or Cu2+, and Ma, Mb = Zn
2+, Cu2+, or (VO)2+) or to a
lesser extent [LMaMb(H2PO4)]
2+ (Ma, Mb = Zn
2+, Cu2+, or
(VO)2+). Since losses of [LMaMb(HPO4)]
2+/+ or
[LMaMb(H2PO4)]
2+ are the result of facile reaction channels,
in contrast to [LMaMb(PO4)]
2+, this suggests an important role
of the phosphate protonation state in the protection
mechanism. Protonation can originate from the initial binding
of the phosphate group to the metal complexes because the
mode of coordination diﬀers depending on the type of the
metal atoms (Figure 5). An additional source of protonation is
proton transfer from the phosphopeptide N-terminus or side
chains to the phosphate group during CID. The mobility of
protons in phosphopeptides has been shown to be a
determining factor for the extent of facile cleavage of phosphate
groups in CID.3,9,45−48 This has led to the generally accepted
model for phosphate detachment from phosphopeptides via
charge-directed SN2 cleavage proposed by Palumbo et al.
45 A
prerequisite for this mechanism is the involvement of either a
mobile proton or participation of a protonated site (protonated
arginine or lysine residues9) under conditions of limited proton
mobility. In the latter case, the protonated site forms strong
hydrogen bonds with the phosphate groups to facilitate charge-
directed SN2 cleavage. The noncovalent interaction modulates
the electron density of the phosphate group making it partially
positive and hence susceptible for nucleophilic attack on the β-
carbon following detachment of the phosphate group and
formation of a protonated oxazoline ring (Figure 7a).
The positive charge of [LMaMb]
n+ bound to phosphopep-
tides should induce suﬃcient coulomb repulsion to prevent
interaction of a proton or protonated residue with the
phosphate group. It is likely that the positively charged metal
complexes induce similar charge delocalization of the
phosphate group as protonated arginine or lysine residues. In
that event, phosphate losses should be predominant for the
highest charged dimetal complex cores ({LGa2}
5+ and
{LIn2}
5+), conclusions which are opposed by the experimental
evidence shown here. We propose the following mechanism for
the pronounced reduction in phosphate detachment observed
for 5+ dimetal complexes. As suggested by Palumbo et al. the
loss of phosphate occurs through a charge-directed cleavage
and formation of a protonated oxazoline ring. However in
contrast to native phosphopeptides, separation of the
[LMaMb(HxPO4)]
n+ ions and the remaining peptide must
occur either through a local neutral−zwitterion or an ion−
zwitterion intermediate depending upon whether a proton is
transferred to the phosphate group from the peptide ion or not
(Figure 7b). We note that other protonated sites in close
proximity to the phosphate group can potentially become
proton donors. Price et al.,49 using blackbody infrared radiative
dissociation, have studied the threshold dissociation energy of
proton-bound dimers between betaine (zwitterionic) and
Table 3. Percentage Loss of H3PO4/[LMaMb(PO4)]
2+ on
CID MS/MS
fragmented precursor dimetal complex/peptide phosphate loss [%]
[methβcas + 2H]2+ 32
[LGa2(methβcas − 2H)]3+ 8.8
[LGa2(methβcas − H)]4+ 8.6
[LIn2(methβcas − 2H)]3+ 5.4
[LIn2(methβcas − H)]4+ 9.1
Figure 7. (a) Phosphate loss from phosphopeptide via charge-directed
SN2 mechanism and (b) proposed mechanism of phosphate ester
protection in DIMPES. Distant charges on the phosphopeptide side
chains and N-terminus not involved in retention of the phosphate
group have been omitted for clarity. RO− = L.
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various bases of diﬀerent GB. The diﬀerent GB of the bases
produces either ion−zwitterion or ion−neutral complexes.
They found that the noncovalent interaction between an ion−
zwitterion with a large dipole moment requires a substantially
larger energy to dissociate than an ion−molecule compound
with a lower dipole moment.49 Similarly, metal complexes
bound to deprotonated phosphate groups will be zwitterions
with large dipole moments. Zwitterions can have signiﬁcantly
smaller GB than ionic molecules. Patrick et al. have shown that
the GB of betaine is substantially smaller than that of the
structurally similar conjugated base of glycine (by 427.1 kJ/
mol).50 This is explained by the zwitterionic nature of betaine,
which provides stabilization of the negative charge and thereby
reduction in GB. For the [LMaMb(βcas)]
n+ studied here, the
larger positive charge of {LGa2}
5+ and {LIn2}
5+ is expected to
induce greatest charge stabilization and hence results in the
largest reduction in the GB of the deprotonated phosphate
group. The experimental results suggest that for {LMaMb}
5+
complexes this reduction in GB causes the phosphate group to
become unable to abstract the proton from the protonated
oxazoline ring formed in the transition state of the exit channel.
The consequence is that dissociation of [LMaMb(PO4)]
2+ from
the peptide has to proceed through an energy demanding ion−
zwitterion state that is likely to exceed the energy needed for
backbone bond cleavages. For {LMaMb}
3+/4+, the lower net
charge of the metal complex ions causes GB of the phosphate
group to be similar or larger than that of the oxazoline ring
resulting in proton transfer to the phosphate and formation of
an ion−molecule intermediate, requiring less vibrational energy
to dissociate. This hypothesis is here substantiated by ab initio
calculations of the GB of [LGa2(PO4)]
2+, [LGaZn(PO4)]
+, and
[LZn2(PO4)] compared to that of a peptide-like oxazoline
compound (2,4-dimethyl-3-oxazoline) (Table 4).
The calculated GB values conﬁrm the expected lowering of
GB of the phosphate group as the metal complex charge
increases. Of the three diﬀerent [LMaMb(PO4)]
n+ only
[LGa2(PO4)]
2+ has a substantially lower GB than 2,4-
dimethyl-3-oxazoline (by 321.1 kJ/mol at B3LYP/6-31G
+(d,p)). For [LGaZn(PO4)]
+ and [LZn2(PO4)], the GB values
are 893.9 and 1221.0 kJ/mol, respectively. These results
support that the bound phosphates in 5+ metal complexes
are unlikely to abstract a proton from the peptide, which makes
cleavage and separation of [LMaMb(PO4)]
2+ from the
phosphopeptides energetically unfavorable compared to
peptide backbone bond cleavages. The opposite is true for
less positively charged dimetallic complexes (3+ and 4+).
■ CONCLUSIONS
We investigated 10 dimetallic complexes of an acyclic
phenolato-hinged heptadentate ligand for their propensity
towards selective and high aﬃnity binding of phosphate esters,
and ability to protect against phosphate detachment from
phosphopeptides in CID MS/MS. Of all complexes tested, only
{LGa2}
5+ reliably decreased the phosphate loss from the βcas
phosphopeptide. Additionally, this complex was the most
selective and displayed the largest Ka for binding phosphate.
Our results suggest that the protective power is related to the
size and charge of the metal ions constituting the phosphate
binding site in the dimetal complexes. We found that only
complexes with a net charge of 5+ on the metal core could
signiﬁcantly prevent phosphate losses from phosphorylated
peptides. The ease of use, selectivity, and ability to decrease
detachment of phosphate during CID analysis means that
[LGa2(OH)2(H2O)2](ClO4)3 is a very interesting reagent for
use in phosphoproteomics . Hav ing found tha t
[LGa2(OH)2(H2O)2](ClO4)3 is superior to a series of related
dimetal complexes, future work should aim at showing the
feasibility of applying the complex in large-scale phosphopro-
teomics with complex samples such as cell lysates and develop
the necessary methodologies for eﬃcient data deconvolution.
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(17) Taus, T.; Köcher, T.; Pichler, P.; Paschke, C.; Schmidt, A.;
Henrich, C.; Mechtler, K. J. Proteome Res. 2011, 10, 5354−5362.
(18) Zubarev, R. A.; Kelleher, N. L.; McLafferty, F. W. J. Am. Chem.
Soc. 1998, 120, 3265−3266.
(19) Syka, J. E.; Coon, J. J.; Schroeder, M. J.; Shabanowitz, J.; Hunt,
D. F. Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 9528−9533.
(20) Mikesh, L. M.; Ueberheide, B.; Chi, A.; Coon, J. J.; Syka, J. E. P.;
Shabanowitz, J.; Hunt, D. F. Biochim. Biophys. Acta, Proteins Proteomics
2006, 1764, 1811−1822.
(21) Stensballe, A.; Jensen, O. N.; Olsen, J. V.; Haselmann, K. F.;
Zubarev, R. A. Rapid Commun. Mass Spectrom. 2000, 14, 1793−1800.
(22) Coon, J. J.; Shabanowitz, J.; Hunt, D. F.; Syka, J. E. J. Am. Soc.
Mass Spectrom. 2005, 16, 880−882.
(23) Svane, S.; Kryuchkov, F.; Lennartson, A.; McKenzie, C. J.;
Kjeldsen, F. Angew. Chem., Int. Ed. 2012, 51, 3216−3219.
(24) Dunn, J. D.; Reid, G. E.; Bruening, M. L. Mass Spectrom. Rev.
2010, 29, 29−54.
(25) Ndassa, Y. M.; Orsi, C.; Marto, J. A.; Chen, S.; Ross, M. M. J.
Proteome Res. 2006, 5, 2789−2799.
(26) Ficarro, S. B.; McCleland, M. L.; Stukenberg, P. T.; Burke, D. J.;
Ross, M. M.; Shabanowitz, J.; Hunt, D. F.; White, F. M. Nat.
Biotechnol. 2002, 20, 301−305.
(27) Ghiladi, M.; McKenzie, C. J.; Meier, A.; Powell, A. K.; Ulstrup,
J.; Wocadlo, S. Dalton Trans. 1997, 0, 4011−4018.
(28) Svane, S.; Kjeldsen, F.; McKee, V.; McKenzie, C. J. Dalton
Trans. [Online early access]. DOI: 10.1039/C5DT00729A. Published
Online: June 9, 2015. http://http://pubs.rsc.org/en/content/
articlelanding/2015/dt/c5dt00729a.
(29) Egdal, R. K.; Bond, A. D.; McKenzie, C. J. Dalton Trans. 2009,
3833−3839.
(30) Ghiladi, M.; Gomez, J. T.; Hazell, A.; Kofod, P.; Lumtscher, J.;
McKenzie, C. J. Dalton Trans. 2003, 1320−1325.
(31) Dalgaard, P.; Hazell, A.; McKenzie, C. J.; Moubaraki, B.;
Murray, K. S. Polyhedron 2000, 19, 1909−1915.
(32) Frisch, M. J.; et al. Gaussian 09; Gaussian, Inc.: Wallingford, CT,
2009.
(33) Klabunde, T.; Strater, N.; Frohlich, R.; Witzel, H.; Krebs, B. J.
Mol. Biol. 1996, 259, 737−748.
(34) Benini, S.; Rypniewski, W. R.; Wilson, K. S.; Ciurli, S.; Mangani,
S. J. Biol. Inorg. Chem. 2001, 6, 778−790.
(35) Coleman, J. E. Annu. Rev. Biophys. Biomol. Struct. 1992, 21, 441−
483.
(36) Ely, F.; Hadler, K. S.; Mitic, N.; Gahan, L. R.; Ollis, D. L.; Plugis,
N. M.; Russo, M. T.; Larrabee, J. A.; Schenk, G. J. Biol. Inorg. Chem.
2011, 16, 777−787.
(37) Han, M. S.; Kim, D. H. Angew. Chem., Int. Ed. 2002, 41, 3809−
3811.
(38) Kinoshita, E.; Takahashi, M.; Takeda, H.; Shiro, M.; Koike, T.
Dalton Trans. 2004, 0, 1189−1193.
(39) Lee, D. H.; Im, J. H.; Son, S. U.; Chung, Y. K.; Hong, J. I. J. Am.
Chem. Soc. 2003, 125, 7752−7753.
(40) Kinoshita, E.; Kinoshita-Kikuta, E.; Takiyama, K.; Koike, T. Mol.
Cell. Proteomics 2006, 5, 749−757.
(41) Egdal, R. K.; Raber, G.; Bond, A. D.; Hussain, M.; Espino, M. P.;
Francesconi, K. A.; McKenzie, C. J. Dalton Trans. 2009, 9718−9721.
(42) Shannon, R. D. Acta Crystallogr. 1976, 32, 751−767.
(43) Hay, R. W. Reaction Mechanisms of Metal Complexes; Horwood
Publishing Limited: Chichester, England, 2000.
(44) Ojida, A.; Hamachi, I. Bull. Chem. Soc. Jpn. 2006, 79, 35−46.
(45) Palumbo, A. M.; Tepe, J. J.; Reid, G. E. J. Proteome Res. 2008, 7,
771−779.
(46) Rozman, M. J. Mass Spectrom. 2011, 46, 949−955.
(47) Laskin, J.; Kong, R. P. W.; Song, T.; Chu, I. K. Int. J. Mass
spectrom. 2012, 330, 295−301.
(48) Gronert, S.; Li, K. H.; Horiuchi, M. J. Am. Soc. Mass Spectrom.
2005, 16, 1905−1914.
(49) Price, W. D.; Jockusch, R. A.; Williams, E. R. J. Am. Chem. Soc.
1998, 120, 3474−3484.
(50) Patrick, J. S.; Yang, S. S.; Cooks, R. G. J. Am. Chem. Soc. 1996,
118, 231−232.
Analytical Chemistry Article
DOI: 10.1021/acs.analchem.5b00257
Anal. Chem. 2015, 87, 7060−7068
7068
